Company / Book Value per Share
Mineralys Therapeutics, Inc. Book Value per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$3.94
FY2024
5-year range
-$10.115 / $6.664
FY2022-FY2024
Trend
-40.9%
vs FY2023
Sector context
#120 of 209
Health Care
What the data says
At $3.94, Mineralys Therapeutics, Inc.'s book value per share ranks #120 of 209 in the Health Care sector. Improved from -$10.115 to $3.94 over the past 2 years.
Based on SEC 10-K filings.
$3.94 in FY2024.
Improved from -$10.115 to $3.94 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#120 of 209 in Health CareTop 57% of 209This company $3.94 Sector average $189.406
▼
-97.9% below sector average
Key checks
Key Insights
- In FY2024, book value per share decreased 40.9% year-over-year.
- Ranks #120 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $3.94 | -40.9% |
| FY2023 | $6.664 | +165.9% |
| FY2022 | -$10.115 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026